Optimizing exercise training for subgroups of patients with chronic heart failure
1National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK.
European Heart Journal
|December 19, 1998
Summary
Exercise intolerance in heart failure stems from peripheral issues, not cardiac output. Peripheral therapies like exercise training can significantly improve exercise capacity and symptoms in patients with left ventricular dysfunction.
Area of Science:
- Cardiology
- Exercise Physiology
- Rehabilitation Medicine
Background:
- Patients with heart failure and severe left ventricular dysfunction experience exercise intolerance.
- This limitation is increasingly attributed to peripheral factors rather than solely cardiac output.
- Peripheral abnormalities include impaired blood flow, skeletal muscle function, and heightened sensitivity to metabolic signals.
Purpose of the Study:
- To investigate the mechanisms underlying exercise limitation in heart failure.
- To explore the potential of peripherally acting therapies, specifically exercise training, to improve exercise tolerance.
Main Methods:
- Review of recent research on exercise intolerance in heart failure.
- Analysis of the effects of exercise training on peripheral components and overall function.
Main Results:
- Exercise limitation is linked to peripheral blood flow and skeletal muscle function deficits.
- Exercise training demonstrates significant improvements in exercise tolerance, comparable to pharmacological interventions like ACE inhibitors.
- Training also enhances ventilatory control, skeletal muscle metabolism, and autonomic nervous system activity.
Conclusions:
- Peripherally acting therapies, particularly exercise training, hold promise for improving exercise tolerance in heart failure.
- Further research is needed to determine optimal exercise protocols and patient selection criteria.
- Tailored exercise rehabilitation can benefit patients with moderate to severe stable heart failure when safety is prioritized.
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
2.9K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.9K
01:20Exercise and Cardiovascular Response
6.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.8K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
1.2K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
01:30Heart Failure V: Medical Management
641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
01:22Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
01:29Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761